Opinion
Jamaican Company Apollon Formularies On Why it Chose London Over North America
Stene Jacobs, COO of Apollon Formularies Plc, elaborates on the potential of the European cannabis industry AFTER two decades of cannabis reform and legal liberalisation across the Europe – especially in the medical sector – what does the modern European landscape look like?